Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on chronic viral hepatitis.

K Walsh1, G J Alexander

  • 1Box 157, Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK.

Postgraduate Medical Journal
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Python farming as a flexible and efficient form of agricultural food security.

Scientific reports·2024
Same author

Early derangement of INR predicts liver failure after liver resection for hepatocellular carcinoma.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2022
Same author

A national survey of the provision of ultrasound surveillance for the detection of hepatocellular carcinoma.

Frontline gastroenterology·2017
Same author

Early primary biliary cholangitis is characterised by brain abnormalities on cerebral magnetic resonance imaging.

Alimentary pharmacology & therapeutics·2016
Same author

STAT4-associated natural killer cell tolerance following liver transplantation.

Gut·2016
Same author

The interaction of genetic determinants in the outcome of HCV infection: evidence for discrete immunological pathways.

Tissue antigens·2015
Same journal

Dapagliflozin-induced anaphylactic shock.

Postgraduate medical journal·2026
Same journal

Comparative efficacy of Janus kinase inhibitors in severe alopecia areata: a network meta-analysis based on randomized controlled trials.

Postgraduate medical journal·2026
Same journal

Two cases of toxic epidermal necrolysis with severe ocular involvement treated with adjunctive tofacitinib.

Postgraduate medical journal·2026
Same journal

Diastolic dysfunction and diabetes: the DIADAD study-a retrospective cohort study from Liverpool.

Postgraduate medical journal·2026
Same journal

Care, cash, and proof: forensic accountability for war-related starvation.

Postgraduate medical journal·2026
Same journal

Response to traumatic injuries in polo players in England.

Postgraduate medical journal·2026
See all related articles

Chronic viral hepatitis B and C remain major global health concerns, causing liver cirrhosis and cancer. While treatments and vaccines improve, ongoing research is vital for managing these persistent liver infections.

Area of Science:

  • Hepatology
  • Virology
  • Infectious Diseases

Background:

  • Chronic viral hepatitis, particularly hepatitis B (HBV) and C (HCV), are significant worldwide causes of liver cirrhosis and hepatocellular carcinoma.
  • Despite HBV vaccination, transmission persists, especially in children, leading to high rates of chronic infection.
  • HCV affects over 1% of the global population, primarily transmitted parenterally, and is a leading cause for liver transplantation.

Purpose of the Study:

  • To provide a timely update on the current understanding and management of chronic viral hepatitis.
  • To review recent advances in therapy and prevention strategies for HBV and HCV infections.
  • To discuss the challenges and outcomes associated with liver transplantation in hepatitis patients.

Main Methods:

Related Experiment Videos

  • Review of recent literature and clinical advances in the management of chronic viral hepatitis.
  • Analysis of transmission routes, disease progression, and therapeutic outcomes for HBV and HCV.
  • Evaluation of treatment efficacy for interferon alfa, nucleoside analogues, and combination therapies.

    • Main Results:

    • Hepatitis B virus (HBV) infection leads to cirrhosis and cancer; nucleoside analogues offer efficacy similar to interferon alfa.
    • Hepatitis C virus (HCV) infection frequently leads to chronic disease, with combination therapy (interferon alfa and ribavirin) achieving up to 40% success.
    • Liver transplantation is an option, but graft reinfection is common for both HBV and HCV, though newer strategies mitigate this.

    Conclusions:

    • Chronic viral hepatitis B and C continue to pose significant global health challenges, necessitating ongoing therapeutic and preventive strategies.
    • Advances in antiviral therapies and post-transplant management have improved outcomes, but challenges like graft reinfection persist.
    • Hepatitis D virus causes additional liver damage in HBV-infected individuals, with limited treatment response, while viruses G and TT have minimal impact.